Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | GPR6 | P46095 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | CCNC | P24863 | 1/20 | 0.46 |
| ▸ | CDK8 | P49336 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29268525 | 0.98 | GAA (0.69) | GAASIGMAR1POLBSMN1; SMN2ALDH1A1 | |
| SCHEMBL6474890 | 0.84 | GAA (0.96) | GAAPOLBSMN1; SMN2ALDH1A1RECQL | |
| SCHEMBL30250263 | 0.84 | GAA (0.50) | GAAPOLBSMN1; SMN2ALDH1A1ALOX15 | |
| SCHEMBL30250433 | 0.84 | GAA (0.50) | GAASIGMAR1POLBSMN1; SMN2ALDH1A1 | |
| SCHEMBL31298060 | 0.84 | SIGMAR1 (0.58) | GAASIGMAR1POLBALDH1A1GPR6 | |
| SCHEMBL29268522 | 0.84 | KMT2A (0.51) | GAAPOLBSMN1; SMN2ALDH1A1ALOX15 | |
| SCHEMBL30250415 | 0.84 | KMT2A (0.65) | GAAPOLBSMN1; SMN2ALDH1A1GPR6 | |
| SCHEMBL29313350 | 0.84 | ALOX5 (0.52) | GAASIGMAR1POLBSMN1; SMN2GPR6 | |
| Hydrochloric Acid SCHEMBL29268527 | 0.83 | NPSR1 (0.49) | GAAPOLBSMN1; SMN2ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL29268529 | 0.83 | ALOX5 (0.51) | GAAPOLBSMN1; SMN2GPR6ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240417385-A1 | COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS | NEUROVENTI INC. (KR) | 2024-12-19 | — | — | US | claimed |
| EP-4400494-A1 | NOVEL COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS | Neuroventi Inc. (KR) | 2024-07-17 | — | — | EP | claimed |
| WO-2023038456-A1 | NOVEL COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS | 건국대학교 글로컬산학협력단 | 2023-03-16 | — | — | WO | claimed |
| US-20240417385-A1 | COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS | NEUROVENTI INC. (KR) | 2024-12-19 | — | — | US | disclosed |
| EP-4400494-A1 | NOVEL COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS | Neuroventi Inc. (KR) | 2024-07-17 | — | — | EP | disclosed |
| US-11858917-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | YALE UNIVERSITY (US) | 2024-01-02 | — | — | US | disclosed |
| WO-2023038456-A1 | NOVEL COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS | 건국대학교 글로컬산학협력단 | 2023-03-16 | — | — | WO | disclosed |
| US-20220089579-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | UNIV YALE (US) | 2022-03-24 | — | — | US | disclosed |
| US-11136316-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the Human Immunodeficiency Virus | YALE UNIVERSITY (US) | 2021-10-05 | — | — | US | disclosed |
| US-20200392121-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-12-17 | — | — | US | disclosed |
| US-10703743-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | YALE UNIVERSITY (US) | 2020-07-07 | — | — | US | disclosed |
| US-20190002447-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-01-03 | — | — | US | disclosed |
| EP-2640720-B1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | YALE UNIV INC (US) | 2018-10-17 | — | — | EP | disclosed |
| US-10030008-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | YALE UNIVERSITY (US) | 2018-07-24 | — | — | US | disclosed |
| US-20170096415-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | UNIV YALE (US) | 2017-04-06 | — | — | US | disclosed |
| US-9562038-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | YALE UNIVERSITY (US) | 2017-02-07 | — | — | US | disclosed |
| EP-2640720-A2 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | Yale University, Inc. (US) | 2013-09-25 | — | — | EP | disclosed |
| US-20130245040-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-09-19 | — | — | US | disclosed |
| WO-2012068366-A9 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | YALE UNIVERSITY (US) | 2013-07-18 | — | — | WO | disclosed |
| WO-2012068366-A2 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | YALE UNIVERSITY (US) | 2012-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240417385-A1 | COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS | ADCYAP1R1, GRIA1, GRIA4 | GAA 19/4885SIGMAR1 3610/4885POLB 4848/4885 |
| US-10703743-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | CD4, HAVCR2, CD2 | GAA 2255/4885SIGMAR1 2452/4885POLB 2105/4885 |
| US-20190002447-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | CD4, HAVCR2, CD2 | GAA 2255/4885SIGMAR1 2452/4885POLB 2105/4885 |
| US-20200392121-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | CD4, HAVCR2, CD2 | GAA 2255/4885SIGMAR1 2452/4885POLB 2105/4885 |
| US-10030008-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | CD4, HAVCR2, CD2 | GAA 2255/4885SIGMAR1 2452/4885POLB 2105/4885 |
| US-11858917-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | CD4, HAVCR2, CD2 | GAA 2255/4885SIGMAR1 2452/4885POLB 2105/4885 |
| US-20170096415-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | CD4, HAVCR2, CD2 | GAA 2255/4885SIGMAR1 2452/4885POLB 2105/4885 |
| US-20220089579-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | CD4, HAVCR2, CD2 | GAA 2255/4885SIGMAR1 2452/4885POLB 2105/4885 |
| US-11136316-B2 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the Human Immunodeficiency Virus | CD4, HAVCR2, CD2 | GAA 2255/4885SIGMAR1 2452/4885POLB 2105/4885 |
| US-20130245040-A1 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | CD4, HAVCR2, CD2 | GAA 2255/4885SIGMAR1 2452/4885POLB 2105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.